ESR1 and breast carcinoma: Our findings suggest the function of PGRMC1 as an important amplifier of ERα-dependent transcription upon treatment with the PPPs NET, DYD, DSP, and MPA, resulting in oncogenic signaling and tumor progression in ERα positive breast cancer cells.